Therapeutic Potential of Annexins in Sepsis and COVID-19
Sepsis is a continuing problem in modern healthcare, with a relatively high prevalence, and a significant mortality rate worldwide. Currently, no specific anti-sepsis treatment exists despite decades of research on developing potential therapies. Annexins are molecules that show efficacy in preclini...
Saved in:
Main Authors: | Louise Mui (Author), Claudio M. Martin (Author), Brent J. Tschirhart (Author), Qingping Feng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19
by: Brent J. Tschirhart, et al.
Published: (2024) -
Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding
by: Brent J. Tschirhart, et al.
Published: (2023) -
Grape exosome-like nanoparticles: A potential therapeutic strategy for vascular calcification
by: Yintong Teng, et al.
Published: (2022) -
Recent Developments in Annexin Biology
Published: (2021) -
Annexins in Influenza Virus Replication and Pathogenesis
by: Patrick Baah Ampomah, et al.
Published: (2018)